|
Real-time Estimate
Other stock markets
|
5-day change | 1st Jan Change | ||
| 26.44 USD | -3.96% |
|
-13.00% | -2.71% |
| 07-08 | Prime Medicine Receives Favorable Ruling in Beam Therapeutics License Arbitration; Shares Rise | MT |
| 07-08 | Prime Medicine Receives Favorable Ruling in Beam Therapeutics License Arbitration | MT |
| Market Cap | 2.74B 2.39B 2.21B 2.04B 3.84B 264B 3.92B 26.41B 10.39B 129B 10.29B 10.07B 445B | P/E 2026 * |
-6.34x | P/E 2027 * | -6.06x |
|---|---|---|---|---|---|
| Enterprise Value | 1.89B 1.65B 1.52B 1.4B 2.64B 182B 2.7B 18.18B 7.15B 88.94B 7.08B 6.93B 306B | EV / Sales 2026 * |
23.9x | EV / Sales 2027 * | 16.3x |
| Free-Float |
98.6% | Yield 2026 * |
-
| Yield 2027 * | - |
Last Transcript: Beam Therapeutics Inc.
| 1 day | -3.92% | ||
| 1 week | -13.00% | ||
| Current month | -21.42% | ||
| 1 month | -24.09% | ||
| 3 months | -13.53% | ||
| 6 months | -12.90% | ||
| Current year | -2.71% |
| 1 week | 26.96 |  | 31.55 |
| 1 month | 26.96 | | 38.26 |
| Current year | 21.63 | | 38.26 |
| 1 year | 15.6 | | 38.26 |
| 3 years | 13.52 | | 49.5 |
| 5 years | 13.52 | | 116.91 |
| 10 years | 13 | | 138.52 |
| Manager | Title | Age | Since |
|---|---|---|---|
John Evans
CEO | Chief Executive Officer | 48 | 31/12/2016 |
Sravan Emany
DFI | Director of Finance/CFO | 48 | 18/12/2024 |
| President | 57 | 23/01/2020 |
| Director | Title | Age | Since |
|---|---|---|---|
John Evans
BRD | Director/Board Member | 48 | 31/12/2016 |
Mark Fishman
BRD | Director/Board Member | 75 | 30/04/2018 |
Graham Cooper
BRD | Director/Board Member | 56 | 09/10/2019 |
| Date | Insider | Type | Main position | Quantity | % Market Cap. | |
|---|---|---|---|---|---|---|
| 30/06/26 | Fiscal year | Chief Executive Officer | 75,000 | 0.0729% | ||
| 30/06/26 | Sell | Chief Technology Officer | -373 | 0.0004% | ||
| 26/06/26 | F-Prime Inc.
| Sell | Company | -251,488 | 0.2444% |
| Change | 5-day change | 1-year change | 3-year change | Capi.($) | ||
|---|---|---|---|---|---|---|
 | -3.96% | -13.00% | +28.25% | -12.94% | 2.74B | |
| -0.39% | -3.87% | +0.75% | +2.43% | 49.18B | |
| -0.56% | +0.86% | +382.90% | +591.76% | 39.58B | |
| -0.08% | +3.07% | +7.31% | +62.41% | 34.69B | |
| -1.26% | -1.87% | +28.13% | -10.03% | 34.42B | |
| +0.06% | +0.34% | +2.38% | +34.47% | 27.11B | |
| -0.75% | -2.27% | - | - | 16.21B | |
| -0.68% | +0.42% | +72.37% | +115.64% | 15.36B | |
| +0.54% | +1.64% | +14.71% | +17.50% | 14.05B | |
| -2.26% | -0.16% | +18.77% | -32.97% | 13.02B | |
| Average | -0.93% | -1.55% | +61.73% | +85.36% | 24.64B | |
| Weighted average by Cap. | -0.55% | -0.35% | +78.72% | +121.01% |
| 2026 * | 2027 * | |
|---|---|---|
| Net sales | 78.87M 68.92M 63.6M 58.62M 110M 7.6B 113M 760M 299M 3.72B 296M 290M 12.81B | 96.07M 83.96M 77.47M 71.41M 135M 9.25B 138M 926M 364M 4.53B 361M 353M 15.6B |
| Net income | -461M -403M -372M -343M -646M -44.41B -660M -4.44B -1.75B -21.75B -1.73B -1.69B -74.87B | -521M -455M -420M -387M -730M -50.15B -746M -5.02B -1.97B -24.56B -1.96B -1.91B -84.55B |
| Net Debt | -855M -747M -689M -635M -1.2B -82.29B -1.22B -8.24B -3.24B -40.3B -3.21B -3.14B -139B | -1.17B -1.02B -945M -871M -1.64B -113B -1.68B -11.29B -4.44B -55.27B -4.4B -4.3B -190B |
| Date | Price | Change | Volume |
|---|---|---|---|
| 20/07/26 | US$27.01 | -1.89% | 305,798 |
| 17/07/26 | US$27.53 | -3.03% | 1,912,917 |
| 16/07/26 | US$28.39 | -7.94% | 4,194,497 |
| 15/07/26 | US$30.84 | -0.16% | 1,395,267 |
| 14/07/26 | US$30.89 | -0.35% | 2,008,765 |
Trader
This super rating is the result of a weighted average of the rankings based on the following ratings: Valuation (Composite), EPS Revisions (4 months), and Visibility (Composite). We recommend that you carefully review the associated descriptions.
Investor
This super composite rating is the result of a weighted average of the rankings based on the following ratings: Fundamentals (Composite), Valuation (Composite), EPS Revisions (1 year), and Visibility (Composite). We recommend that you carefully review the associated descriptions.
Global
This composite rating is the result of an average of the rankings based on the following ratings: Fundamentals (Composite), Valuation (Composite), Financial Estimates Revisions (Composite), Consensus (Composite) and Visibility (Composite). The company must be covered by at least 4 of these 5 ratings for the calculation to be carried out. We recommend that you carefully review the associated descriptions.
Quality
This composite rating is the result of an average of rankings based on the following ratings: Returns (Composite), Profitability (Composite) and Quality of Financial Reporting (Composite), and Financial Health (Composite). The company must be covered by at least 2 of these 3 ratings for the calculation to be performed. We recommend that you carefully read the associated descriptions.
ESG MSCI
The MSCI ESG score assesses a company’s environmental, social, and governance practices relative to its industry peers. Companies are rated from CCC (laggard) to AAA (leader). This rating helps investors incorporate sustainability risks and opportunities into their investment decisions.
Quarterly revenue - Rate of surprise
- Stock Market
- Stocks
- BEAM Stock
Select your edition
All financial news and data tailored to specific country editions
